FindTrial
Sign In

Evaluation of Radioiodine Scintigraphy (123I) with SPECT/CT prepared with rhTSH, for the Detection of Distant Metastasis 5-years after thyroidectomy in patients with differentiated thyroid cancer

Evaluation of Radioiodine Scintigraphy (123I) with SPECT/CT prepared with rhTSH, for the Detection of Distant Metastasis 5-years after thyroidectomy in patients with differentiated thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004216
Enrollment
421
Registered
2019-08-20
Start date
2019-08-20
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sanofi-Aventis Korea
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 20- 70 year old male and female patients total thyroidectomy Total thyroidectomy performed at Gangnam Severance Hospital between January 2010 and December 2011 visiting the outpatient clinic for 5-year postoperative follow-up and who were scanned with SPECT/CT and treated with rhTSH between September 2016 and September 2016

Exclusion criteria

Exclusion criteria: contraindication to RAI treatment patients with no thyroglobulin level measured before and afer treatment pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
distant metastasis—

Secondary

MeasureTime frame
thyroglobulin—

Countries

Korea, Republic of

Contacts

Public ContactHang-Seok Chang

Yonsei University Health System, Gangnam Severance Hospital

SURGHSC@yuhs.ac+82-2-2019-3370

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026